Showing results (91-100 of 472) with videos related to
Sort By:
Pageof 48
Therapeutic Advances in Cardiovascular Disease|June 23, 2017
Metabolic syndrome: pathophysiology, management, and modulation by natural compoundsYogita Rochlani, Naga Venkata Pothineni, Swathi Kovelamudi, et al.Therapeutic Advances in Cardiovascular Disease|December 8, 2009
Current pharmacotherapeutic concepts for the treatment of cardiovascular disease in diabeticsPeter Highlander, Graham P ShawTherapeutic Advances in Cardiovascular Disease|June 21, 2018
Sacubitril/valsartan in cardiovascular disease: evidence to date and place in therapySrikanth Yandrapalli, Mohammed Hasan Khan, Yogita Rochlani, et al.Therapeutic Advances in Cardiovascular Disease|July 4, 2014
Current state of endothelin receptor antagonism in hypertension and pulmonary hypertensionKazuya Miyagawa, Noriaki EmotoTherapeutic Advances in Cardiovascular Disease|March 19, 2015
The relationship of TIMI risk index with SYNTAX and Gensini risk scores in predicting the extent and severity of coronary artery disease in patients with STEMI undergoing primary percutaneous coronary interventionHalit Acet, Faruk Ertaş, Mehmet Zihni Bilik, et al.Therapeutic Advances in Cardiovascular Disease|April 25, 2015
Current approaches to atherosclerotic obstructive renal artery stenosisLuis I Juncos, Stephen TextorTherapeutic Advances in Cardiovascular Disease|June 4, 2015
Sesamin enhances nitric oxide bioactivity in aortas of spontaneously hypertensive ratsXiang Kong, Wei Li, Li-qun Guo, et al.Therapeutic Advances in Cardiovascular Disease|June 4, 2015
Ten year experience of using a novel metabolic protocol in 'off pump' coronary artery bypass revascularizationDavid J Perkowski, Susan Wagner, Kathryn Muller, et al.Therapeutic Advances in Cardiovascular Disease|January 25, 2026
Troponins and echocardiography: role in detecting myocardial injury in burn patientsMohammed AbuBaha, Samia Aldwaik, Ameer Awashra, et al.Therapeutic Advances in Cardiovascular Disease|November 12, 2025
Neurological efficacy and safety of RNA therapeutics in hereditary transthyretin amyloidosis: a systematic review and meta-analysis of randomized controlled trialsMaha Sajjad, Rabia Ashraf, Riya Bhagwan, et al.Pageof 48